Showing results (21-30 of 52) with videos related to
Sort By:
Pageof 6
Cancer Chemotherapy and Pharmacology|August 24, 2023
Pazopanib pharmacokinetically guided dose optimization in three cancer patients with gastrointestinal resectionCléa Tardy, Alicja Puszkiel, Pascaline Boudou-Rouquette, et al.Genes|July 10, 2020
Prognostic Significance of RAS Mutations and P53 Expression in Cutaneous Squamous Cell CarcinomasManuel António Campos, Sofia Macedo, Margarida Sá Fernandes, et al.British Journal of Clinical Pharmacology|January 29, 2023
Cardiac toxicity associated with pharmacokinetic drug-drug interaction between crizotinib and sofosbuvir/velpatasvir: A case reportAnthia Monribot, Olivier Huillard, Nihel Khoudour, et al.Journal of Dermatological Science|October 5, 2013
Mitochondrial D310 D-Loop instability and histological subtypes in radiation-induced cutaneous basal cell carcinomasPaula Boaventura, Dina Pereira, Adélia Mendes, et al.European Journal of Clinical Pharmacology|March 23, 2023
Predictive factors associated with pemetrexed acute toxicityMathilde Bonnet, Anne Jouinot, Pascaline Boudou-Rouquette, et al.Cancers|April 30, 2021
Genetic Determinants for Prediction of Outcome of Patients with Papillary Thyroid CarcinomaAntónia Afonso Póvoa, Elisabete Teixeira, Maria Rosa Bella-Cueto, et al.Retina (Philadelphia, Pa.)|May 29, 2015
SPIRONOLACTONE FOR NONRESOLVING CENTRAL SEROUS CHORIORETINOPATHY: A RANDOMIZED CONTROLLED CROSSOVER STUDYElodie Bousquet, Talal Beydoun, Pierre-Raphaël Rothschild, et al.Surgery|August 31, 2016
pmTOR is a marker of aggressiveness in papillary thyroid carcinomasCatarina Tavares, Maria João Coelho, Miguel Melo, et al.The Journal of Investigative Dermatology|April 3, 2014
TERT promoter mutations in skin cancer: the effects of sun exposure and X-irradiationHelena Pópulo, Paula Boaventura, João Vinagre, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 14, 2025
Factors associated with medication adherence trajectory among patients treated with oral anticancer drugs: a multicentre cohort studyGermain Perrin, Audrey Thomas-Schoemann, François Goldwasser, et al.Pageof 6